Imaging uncovers mixed results for nicotine vaccine

06/14/2013 | Diagnostic Imaging

Results from PET scans were mixed for an experimental vaccine aimed at lowering the amount of nicotine that reaches the brains of smokers, according to findings presented at the SNMMI Annual Meeting. "Ideally, we want [the vaccine] to decrease amount of nicotine that reaches the brain, but when we compared the immune response across subjects, their antibodies appeared to vary in nicotine-binding properties," said Dr. Alexey Mukhin of Duke University.

View Full Article in:

Diagnostic Imaging

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL